Pfizer’s Exubera Launch Now Slated For July
This article was originally published in The Pink Sheet Daily
Executive Summary
The company had previously said that the inhaled insulin would be available in June; it was approved in January.
You may also be interested in...
Exubera Launch Falls Back To Early Autumn
Pfizer will roll out an education program for physicians and patients at the end of July and will launch the inhaled insulin in September.
Exubera Launch Falls Back To Early Autumn
Pfizer will roll out an education program for physicians and patients at the end of July and will launch the inhaled insulin in September.
Exubera Labeling Could Trigger Dosing Errors, ISMP Says
Due to potential confusion between converting doses of inhaled insulin to units of injectable insulin, current labeling and dosing instructions should not have been approved, hazard alert says.